The Risk Management Plan (RMP) is a document required for all MA applications in Europe.
It describes identified and potential risks of a medicine, along with planned monitoring and minimisation measures. The RMP is regularly updated to include new real-world safety data.
It is a key tool for proactive pharmacovigilance.
FIND US
Aroma, Parc d’activités, 45 Bd Marcel Pagnol, 06130 Grasse
Mon-Fri: 9:00 AM – 6:00 PM
Discover our main services to help you address the French Market.
Market Access
The Exploitant Status
Post Market Surveillance
Supply Chain Optimization
Promotion & Sales
We operate in the following areas of expertise.
Orphan Drugs
Hospital Market
Blood Derived products
ATMPs
Regulatory Compliance
